Personal stories

A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.

Check out this infographic breakdown of the company’s third-quarter 2023 performance, with key highlights from its Innovative Medicine and MedTech businesses.

They share similar symptoms, sure. But these three distinct conditions have distinct causes, occur in people of varying ages and have their own treatments. Read on for the key differences.

When health workers feel supported and cared for, they are better able to provide care in a manner that respects patients’ dignity and humanity.

Rocky Camaligan has designed and integrated a health education program that promotes physical and mental health among patients, health workers and the wider community.

Learn how new technology from Johnson & Johnson aims to be a game-changer not only for patients but for surgeons, too.

With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.

The Mental Health Navigation model improves patient health outcomes and offers a blueprint to deliver mental health services cost-effectively within communities.